Back
Innate Pharma SA Vs. Preformed Line Products Industry Stock Comparison
Sell
49
IPHA
Innate Pharma SA
Last Price:
$1.98
Seasonality Move:
1.21%
Buy
62
PLPC
Preformed Line Products
Last Price:
$144.96
Seasonality Move:
7.37%
Sell
49
Innate Pharma SA (IPHA)
is a Sell
Is Innate Pharma SA a Buy, Sell or Hold?
-
The current Innate Pharma SA [IPHA] share price is $2.00. The Score for IPHA is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
IPHA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Preformed Line Products (PLPC)
is a Buy
Is Preformed Line Products a Buy, Sell or Hold?
-
The current Preformed Line Products [PLPC] share price is $145.03. The Score for PLPC is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
PLPC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IPHA Stock Price Chart
What is Innate Pharma SA's stock price today?
-
The Innate Pharma SA share price today is $2.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPHA is experiencing buying pressure, which is a positive indicator for future bullish movement.
PLPC Stock Price Chart
What is Preformed Line Products's stock price today?
-
The Preformed Line Products share price today is $145.03Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLPC is experiencing slight buying pressure.
IPHA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 47.49 | Sell |
Chaikin Money Flow: | 17923 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.94 - 2.2) | Sell |
Bollinger Bands (100): | (1.63 - 2.13) | Buy |
PLPC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.44 | Sell |
Relative Strength Index (14 RSI): | 66.47 | Buy |
Chaikin Money Flow: | 15747 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (125.53 - 143.37) | Buy |
Bollinger Bands (100): | (124.98 - 140.1) | Buy |
IPHA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.04 | Sell |
20-day SMA: | 2.1 | Sell |
50-day SMA: | 1.94 | Buy |
200-day SMA: | 2.08 | Sell |
8-day EMA: | 2.04 | Sell |
20-day EMA: | 2.05 | Sell |
50-day EMA: | 1.99 | Buy |
200-day EMA: | 2.08 | Sell |
PLPC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 125.58 | Buy |
20-day SMA: | 131.95 | Buy |
50-day SMA: | 133.54 | Buy |
200-day SMA: | 128.03 | Buy |
8-day EMA: | 129.06 | Buy |
20-day EMA: | 130.88 | Buy |
50-day EMA: | 132.75 | Buy |
200-day EMA: | 130.26 | Buy |
Innate Pharma SA Earnings Growth & IPHA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Preformed Line Products Earnings Growth & PLPC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Innate Pharma SA Technical Analysis
Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Preformed Line Products Technical Analysis
Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |